BELLUS Health (BLU) Stock Price, News & Analysis

Company Overview

Bluenergies Ltd. is engaged in the business of mineral exploration and the acquisition of mineral property assets in Canada. Its objective is to locate and develop economic precious and base metal properties of merit and to conduct its exploration program on the Lemon Lake Property.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 28,666 shs
• Average Volume: 59,471 shs
• Market Capitalization: C$2.47 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BLU Stock Analysis - Frequently Asked Questions

How do I buy shares of BELLUS Health?

Shares of BLU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of BELLUS Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BELLUS Health investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Advanced Micro Devices (AMD), Algonquin Power & Utilities (AQN), BCE (BCE), Canadian Natural Resources (CNQ) and Nutrien (NTR).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: TSE:BLU
• CIK: N/A
• Web: www.bellushealth.com
• Phone: +1-450-6804500
• Fax: N/A
• Employees: 74
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.96)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$86.79 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -26.76%
• Return on Assets: -16.70%

Debt

• Debt-to-Equity Ratio: 0.32
• Current Ratio: 33.42
• Quick Ratio: 16.40

Sales & Book Value

• Annual Sales: C$16 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.67
• Book Value: C$2.91 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 126,810,000
• Free Float: N/A
• Market Cap: C$2.47 billion
• Optionable: Not Optionable
• Beta: -0.28